BioNxt Solutions Inc. (CVE:BNXT) | WebDisclosure

Basculer en Français

10604	Companies
225013	Keywords
153734	Articles
119074	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

PRESS RELEASE

published on 09/29/2025 at 09:05, 8 months 22 days ago

BioNxt Reports Sublingual Cladribine Multiple Sclerosis Drug Milestones Including Large-Animal Study for Validation and Dosing Optimization
BioNxt Solutions provides update on Cladribine sublingual thin-film drug reformulation program, targeting treatment of multiple sclerosis with improved bioavailability and patient adherence

Multiple Sclerosis Cladribine Neurological Disorders BioNxt Solutions Drug Delivery Technologies
BRIEF

published on 09/20/2025 at 03:50, 9 months 1 day ago

BioNxt Solutions lève des actions pour régler sa dette

Actions Ordinaires Règlement De La Dette Solutions BioNxt Valeurs Mobilières Canadiennes Accord De Dette
BRIEF

published on 09/20/2025 at 03:50, 9 months 1 day ago

BioNxt Solutions Completes Shares for Debt Settlement

Common Shares Debt Settlement Debt Agreement Canadian Securities BioNxt Solutions
PRESS RELEASE

published on 09/20/2025 at 03:45, 9 months 1 day ago

BioNxt Solutions Announces Closing of Shares for Debt Settlement
BioNxt Solutions Inc. announces successful debt settlement with creditor, issuing common shares and making cash payment. Company focuses on bioscience innovation and drug delivery technologies

Common Shares Debt Settlement BioNxt Solutions Inc. Drug Delivery Technologies Bioscience Innovation
BRIEF

published on 09/20/2025 at 01:35, 9 months 1 day ago

BioNxt Solutions Inc. fait appel à des conseillers en marchés financiers et à des professionnels des relations avec les investisseurs.

Relations Avec Les Investisseurs Marchés Des Capitaux Options Sur Actions Solutions BioNxt Terry Lynch
BRIEF

published on 09/20/2025 at 01:35, 9 months 1 day ago

BioNxt Solutions Inc. Engages Capital Markets Advisor and Investor Relations Professionals

Stock Options Investor Relations Capital Markets BioNxt Solutions Terry Lynch
PRESS RELEASE

published on 09/20/2025 at 01:30, 9 months 1 day ago

Terry Lynch Continues as Capital Markets Advisor and BioNxt Retains Investor Relations Professionals
BioNxt Solutions Inc. announces Terry Lynch as capital markets advisor and retention of two investor relations professionals, Rob Grace and Blaine Ruzcki, for promotional activities. Company focuses on bioscience innovations with drug delivery platforms

BioNxt Solutions Inc. Terry Lynch Investor Relations Professionals Bioscience Innovations Drug Delivery Platforms
BRIEF

published on 09/15/2025 at 09:10, 9 months 6 days ago

BioNxt progresse avec son programme de films oraux à base de sémaglutide

Dépôt De Brevet Développement De Prototypes BioNxt Semaglutide ODF Marché Du GLP-1
BRIEF

published on 09/15/2025 at 09:10, 9 months 6 days ago

BioNxt Progresses with Semaglutide Oral Film Program

Patent Filing Prototype Development BioNxt Semaglutide ODF GLP-1 Market
PRESS RELEASE

published on 09/15/2025 at 09:05, 9 months 6 days ago

BioNxt Advances Semaglutide Oral Dissolvable Film (ODF) Program with Successful Proof-of-Concept and Prototype Development
BioNxt achieves successful proof-of-concept trials for Semaglutide oral dissolvable film program, advancing to next development phase in GLP-1 market for diabetes and obesity therapies

Drug Delivery Semaglutide BioNxt GLP-1 Market Proof-of-concept

Accesswire

Published on 06/20/2026 at 01:00, 1 day 12 hours ago

Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 1 day 13 hours ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 2 days 8 hours ago

Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 2 days 11 hours ago

American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 2 days 12 hours ago

Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting

View all ACCESSWIRE

EQS Group

Published on 06/20/2026 at 21:25, 15 hours 48 minutes ago

VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 1 day 7 hours ago

Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 16 hours ago

2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 1 day 16 hours ago

2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 1 day 18 hours ago

Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting

Les Echos

Published on 06/19/2026 at 19:33, 1 day 17 hours ago

Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 1 day 17 hours ago

Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 17 hours ago

Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 1 day 17 hours ago

Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/19/2026 at 19:05, 1 day 18 hours ago

CP - Changement de gouvernance

View all LES ECHOS COMFI WIRE